Malaysia Exempts Low-Risk Devices From Conformity Assessment, But Registration Mandatory
This article was originally published in SRA
Executive Summary
The Malaysian government exempted all types of Class A (lowest-risk) devices from conformity assessment requirements as of April 18 to make it easier for companies to bring such products to the market1. These devices, however, will have to continue complying with other regulatory requirements such as labelling and post-marketing commitments.
You may also be interested in...
Malaysian Medtech Agency Introduces New Fee To Tackle Surge In Product Classification Enquiries
The Malaysian medtech regulator says an increase in product classification-related enquiries is causing a drain on its resources and the service should be supported by a fee.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.